MyAverix Finance
HK · Healthcare
Xuanzhu Biopharm Co Ltd (2575)
Drug Manufacturers - Specialty & Generic
Xuanzhu Biopharm Co Ltd (2575) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $9.15B, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2575
Xuanzhu Biopharm Co Ltd (2575) — FAQ
What is Xuanzhu Biopharm Co Ltd's market cap?
Xuanzhu Biopharm Co Ltd (2575) has a reported market cap of $9.15B (data as of 2026-05-21).
What is 2575's P/E ratio?
The price-to-earnings (P/E) ratio for Xuanzhu Biopharm Co Ltd (2575) is 18.00 (data as of 2026-05-21).
Does Xuanzhu Biopharm Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Xuanzhu Biopharm Co Ltd (2575). Check the MyAverix Finance app for the latest dividend data.
What sector is Xuanzhu Biopharm Co Ltd in?
Xuanzhu Biopharm Co Ltd (2575) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 2575 listed on?
2575 is listed on HK.
What is Xuanzhu Biopharm Co Ltd's net margin?
Xuanzhu Biopharm Co Ltd (2575) reports a net margin of 0.0% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.